Introduction
Diabetes mellitus is a long-term metabolic disorder that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, and unexplained weight loss. Insulin, a pancreatic hormone, helps glucose from food get into the cells to be used for energy. [1] Diabetes mellitus type-2 is defined as a metabolic disorder that results in hyperglycemia (high blood glucose levels) due to the body: • Developing insulin resistance • Being unable to produce enough insulin.
The American Heart Association (AHA) and American Diabetes Association (ADA) have given a cautious nod to the use of artificial sweeteners in place of sugar to combat obesity, metabolic syndrome, and diabetes, all risk factors for heart disease.
development of resistance to insulin by the body. An important factor nowadays thought to be involved is faulty or inappropriate food habits-junk food, high-fat and high-carbohydrate diet with low fiber content. [4] According to some studies, the prime reason for development of diabetes mellitus is believed to be artificial sweeteners. In one study, people were given either sucralose or water and then subjected to glucose tolerance test. Those given sucralose had higher blood insulin levels. [5, 6] Another study compared a dose-dependent relationship between artificially sweetened soft drinks and risk of type-2 diabetes mellitus. [7] This study aims to correlate insulin resistance with consumption of artificial sweeteners.
Aims and Objectives
This study is designed to find any correlation between ingestion of artificial sweetening agents and their effect on insulin resistance. The blood glucose and serum insulin levels of the patients were recorded and insulin resistance was calculated using the HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) calculator and scale, developed by Matthew et al. [8] Methodology Study Type: It is a cross-sectional observational study.
Inclusion Criteria
Exclusion Criteria 1) Patients who have given a written consent. 1) Patients suffering from any other endocrinological illness.
2) Patients diagnosed with type-2 DM.
2) Patients suffering from gestational diabetes mellitus 3) Patients consuming artificial sweetening agents.
3) Patients with type-2 DM, receiving insulin therapy.
Study Design:
The study will be conducted on patients diagnosed with type-2 diabetes mellitus of a tertiary care hospital in Central India.
Sample Size:
Patients with type-2 diabetes mellitus irrespective of their age and gender, presenting in the hospital OPD will be a part of this study.
After a written consent has been achieved, the sample will be divided into two groups: 1. Group A -The patients who regularly consume artificial sweetening agents 2. Group B -The patients who do not consume artificial sweeteners in any form.
Patients from both the groups will be tested for fasting blood sugar levels and serum insulin, individually. Insulin resistance will be calculated by applying the values of both the parameters in the HOMA-IR calculator.
The information will be kept confidential and under quality control.
HOMA-IR provides us with the scales of insulin resistance using a basic mathematical algorithm, given as: [7] Substituting the values for serum insulin and FBS in the above formula, insulin resistance can be easily calculated.
To assess insulin resistance, HOMA-IR also provides a scale or classification as: [7] Normal Insulin Resistance Less than 3 Moderate Insulin Resistance 3-5 Severe Insulin Resistance Above 5
For an individual with no history of type-2 diabetes mellitus, the HOMA-IR reading should fall below 3.
For example, for a person with FSL of 100 (Normal = 70-110 mg/dl) and serum insulin of 10 (normal = 5-20 mU/L), the HOMA-IR reading will be = 2.46 (below 3) which is normal.
Moreover, if a patient currently is under the "Moderate" class, the patient has the probability to develop type-2 diabetes mellitus in future.
The data from groups A and B were compared for analysis of insulin resistance.
Observations and Result
Volunteers from both the groups were well informed and after obtaining their consent, blood was drawn and tested for fasting serum insulin levels and fasting serum glucose levels which were recorded.
U sing the above data, the volunteers had their HOMA-IR value calculated and individually noted and charted as follows:
Group A:
The HOMA-IR values for Group A and B ranged from 0.9-24.33 and 0.12-10.83 with mean values 7.39 and 2.6, respectively [ Figures 1 and 2 ]. Both the charts were matched, checked with the data, and the findings were noted. Volume 9 : Issue 1 : January 2020
Discussion
A similar study carried out by de Koning et al. in 2011 compared the development of diabetes mellitus type-2 with the consumption of artificially sweetened beverages and sugar-sweetened beverages (SSB) [ Figure 3 ]. [9] Increased intake of artificial sweetened beverages increased the incidence of type-2 diabetes, suggesting possible mechanism of insulin resistance over time.
Another study carried out in 2016 by Löfvenborg JE et al. [10] showed a positive correlation between sugar-sweetened beverages and development of LADA.
Recent studies have shown that sucrose or sucralose increase the T1R2 and T1R3 taste receptors that in turn stimulated the intestine and circulating levels of GIP and GLP-1 leading to hyperinsulinemia. [11] Conclusion Group A patients who consumed artificial sweetening agents had higher insulin resistance as compared to group B patients who had no artificial sweeteners based on HOMA-IR. However, further studies are required to conclude a direct correlation of artificial sweeteners with decreased insulin sensitivity.
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